Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: Phase 1 results from the multicenter EVOLUTION study

S. K. Kumar, I. Flinn, S. J. Noga, P. Hari, R. Rifkin, N. Callander, M. Bhandari, J. L. Wolf, C. Gasparetto, A. Krishnan, D. Grosman, J. Glass, E. A. Sahovic, H. Shi, I. J. Webb, P. G. Richardson, S. V. Rajkumar

Research output: Contribution to journal › Article › peer-review

71 Scopus citations

Fingerprint

Dive into the research topics of 'Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: Phase 1 results from the multicenter EVOLUTION study'. Together they form a unique fingerprint.

Medicine & Life Sciences